Literature DB >> 12511581

New weapons against inflammation: dual inhibitors of phospholipase A2 and transglutaminase.

Lucio Miele1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12511581      PMCID： PMC151842          DOI： 10.1172/JCI17506

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  12 in total

1.  The anti-inflammatory peptides, antiflammins, regulate the expression of adhesion molecules on human leukocytes and prevent neutrophil adhesion to endothelial cells.

Authors:  C Zouki; S Ouellet; J G Filep
Journal:  FASEB J       Date:  2000-03       Impact factor: 5.191

Review 2.  Modulation of cellular response to antigens by uteroglobin and transglutaminase.

Authors:  A B Mukherjee; E Cordella-Miele; T Kikukawa; L Miele
Journal:  Adv Exp Med Biol       Date:  1988       Impact factor: 2.622

Review 3.  Antiflammins. Bioactive peptides derived from uteroglobin.

Authors:  L Miele
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

Review 4.  Phospholipase A2.

Authors:  Makoto Murakami; Ichiro Kudo
Journal:  J Biochem       Date:  2002-03       Impact factor: 3.387

5.  Lys 43 and Asp 46 in alpha-helix 3 of uteroglobin are essential for its phospholipase A2 inhibitory activity.

Authors:  Bhabadeb Chowdhury; Giuditta Mantile-Selvaggi; Lucio Miele; Eleonora Cordella-Miele; Zhongjian Zhang; Anil B Mukherjee
Journal:  Biochem Biophys Res Commun       Date:  2002-07-26       Impact factor: 3.575

Review 6.  Transglutaminase 2: an enigmatic enzyme with diverse functions.

Authors:  Laszlo Fesus; Mauro Piacentini
Journal:  Trends Biochem Sci       Date:  2002-10       Impact factor: 13.807

Review 7.  Anti-inflammatory actions of glucocorticoids: molecular mechanisms.

Authors:  P J Barnes
Journal:  Clin Sci (Lond)       Date:  1998-06       Impact factor: 6.124

8.  Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis.

Authors:  Joonhong Sohn; Tae-Im Kim; Young-Hee Yoon; Joo-Yong Kim; Soo-Youl Kim
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

9.  A novel transglutaminase-mediated post-translational modification of phospholipase A2 dramatically increases its catalytic activity.

Authors:  E Cordella-Miele; L Miele; A B Mukherjee
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

10.  Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I.

Authors:  L Miele; E Cordella-Miele; A Facchiano; A B Mukherjee
Journal:  Nature       Date:  1988-10-20       Impact factor: 49.962
View more
  4 in total

Review 1.  Roles of transglutaminases in cardiac and vascular diseases.

Authors:  David C Sane; Jimmy L Kontos; Charles S Greenberg
Journal:  Front Biosci       Date:  2007-01-01

2.  Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality.

Authors:  Justin M Snider; Jeehyun Karen You; Xia Wang; Ashley J Snider; Brian Hallmark; Manja M Zec; Michael C Seeds; Susan Sergeant; Laurel Johnstone; Qiuming Wang; Ryan Sprissler; Tara F Carr; Karen Lutrick; Sairam Parthasarathy; Christian Bime; Hao Helen Zhang; Chiara Luberto; Richard R Kew; Yusuf A Hannun; Stefano Guerra; Charles E McCall; Guang Yao; Maurizio Del Poeta; Floyd H Chilton
Journal:  J Clin Invest       Date:  2021-10-01       Impact factor: 14.808

3.  Proteomic signatures of human oral epithelial cells in HIV-infected subjects.

Authors:  Elizabeth Yohannes; Santosh K Ghosh; Bin Jiang; Thomas S McCormick; Aaron Weinberg; Edward Hill; Faddy Faddoul; Mark R Chance
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

4.  Selective targeted delivery of the TNF-alpha receptor p75 and uteroglobin to the vasculature of inflamed tissues: a preliminary report.

Authors:  Elisa Ventura; Enrica Balza; Laura Borsi; Giorgia Tutolo; Barbara Carnemolla; Patrizia Castellani; Luciano Zardi
Journal:  BMC Biotechnol       Date:  2011-11-10       Impact factor: 2.563
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.